Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography
Objective: To investigate the influence of cardiovascular risk factors, including fasting plasma glucose (FPG), on the association between electrocardiographic (ECG) and echocardiographic left ventricular hypertrophy (LVH) in an elderly population. Methods: We tested cross-sectional associations bet...
Gespeichert in:
| Veröffentlicht in: | Blood pressure 2017-01, Vol.26 (1), p.54-63 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 63 |
|---|---|
| container_issue | 1 |
| container_start_page | 54 |
| container_title | Blood pressure |
| container_volume | 26 |
| creator | Petersen, Søren Sandager Pedersen, Line Reinholdt Pareek, Manan Nielsen, Mette Lundgren Diederichsen, Søren Zöga Leósdóttir, Margrét Nilsson, Peter M. Diederichsen, Axel Cosmus Pyndt Olsen, Michael Hecht |
| description | Objective: To investigate the influence of cardiovascular risk factors, including fasting plasma glucose (FPG), on the association between electrocardiographic (ECG) and echocardiographic left ventricular hypertrophy (LVH) in an elderly population.
Methods: We tested cross-sectional associations between electrocardiographic and echocardiographic LVH, defining LVH according to the Sokolow-Lyon voltage combination, Cornell voltage-duration product, or left ventricular mass index (LVMI). Differences between standardized LVMI and Sokolow-Lyon voltage combination or Cornell voltage-duration product (absolute value/cut-off value for LVH) were used as outcome variables in order to identify explanatory variables associated with diagnostic discrepancies between ECG and echocardiography.
Results: Of the 1382 subjects included, 77% did not display any signs of LVH, 6% had LVH defined by ECG only, 13% had LVH defined by echocardiography only, and 5% had LVH on both ECG and echocardiography. Older subjects and those with higher blood pressure and RWT were more likely to have a relatively greater LVMI on echocardiography than that predicted on ECG (odds ratio: 1.65 per 10 years (95% confidence interval (CI): 1.27-2.15), p = .0002, odds ratio: 1.17 per 10 mmHg (95% CI: 1.09-1.25), p |
| doi_str_mv | 10.1080/08037051.2016.1235959 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_08037051_2016_1235959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_19d95cea06d74606bee3bf87563c9d94</doaj_id><sourcerecordid>1835384776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-9ac4aa0aa9353aca36d72a82048dac3d1054fbf85d1b4aa11c47666364cc7fee3</originalsourceid><addsrcrecordid>eNp9UsFu1DAQjRCILoVPAOXIJYsdx058A1UUKq3EBc7W2B7vpsrGwXZY5dZPx2G3lXrhMLI18-Y9zcwriveUbCnpyKccrCWcbmtCxZbWjEsuXxQbKjitqJTyZbFZMdUKuirexHhPCGWMkNfFVd0KUUvSbYqHWzDJh1hCjN70kNCWpz4dStvDfvQx9SZ_owk4wWiW0vlQDuhS-QfHFHozDxDKwzJhSMFPh6XUmE6IY4kDmpwyEGzv9wHWGoy2RHN4lnxbvHIwRHx3ea-LX7dff958r3Y_vt3dfNlVhhOaKgmmASAAknEGBpiwbQ1dTZrOgmGWEt447Tpuqc5ASk2TZxRMNMa0DpFdF3dnXuvhXk2hP0JYlIde_Uv4sFcQ8rQDKiqt5AaBZI1GEKFze6ZuuWAml5rMtTtzxRNOs37GNsxTDp1DRVTOdB1KLRWQWqqmQamkw1YxDVpQbQXvXKb7eKabgv89Y0zqmDeOwwAj-jkq2uWZu6ZtRYbyM9QEH2NA96RNiVp9oR59oVZfqIsvct-Hi8Ssj2ifuh6NkAGfz4B-zCc-wsmHwaoEy-CDC_n0fVTs_xp_Ab_Ny48</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835384776</pqid></control><display><type>article</type><title>Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Petersen, Søren Sandager ; Pedersen, Line Reinholdt ; Pareek, Manan ; Nielsen, Mette Lundgren ; Diederichsen, Søren Zöga ; Leósdóttir, Margrét ; Nilsson, Peter M. ; Diederichsen, Axel Cosmus Pyndt ; Olsen, Michael Hecht</creator><creatorcontrib>Petersen, Søren Sandager ; Pedersen, Line Reinholdt ; Pareek, Manan ; Nielsen, Mette Lundgren ; Diederichsen, Søren Zöga ; Leósdóttir, Margrét ; Nilsson, Peter M. ; Diederichsen, Axel Cosmus Pyndt ; Olsen, Michael Hecht</creatorcontrib><description>Objective: To investigate the influence of cardiovascular risk factors, including fasting plasma glucose (FPG), on the association between electrocardiographic (ECG) and echocardiographic left ventricular hypertrophy (LVH) in an elderly population.
Methods: We tested cross-sectional associations between electrocardiographic and echocardiographic LVH, defining LVH according to the Sokolow-Lyon voltage combination, Cornell voltage-duration product, or left ventricular mass index (LVMI). Differences between standardized LVMI and Sokolow-Lyon voltage combination or Cornell voltage-duration product (absolute value/cut-off value for LVH) were used as outcome variables in order to identify explanatory variables associated with diagnostic discrepancies between ECG and echocardiography.
Results: Of the 1382 subjects included, 77% did not display any signs of LVH, 6% had LVH defined by ECG only, 13% had LVH defined by echocardiography only, and 5% had LVH on both ECG and echocardiography. Older subjects and those with higher blood pressure and RWT were more likely to have a relatively greater LVMI on echocardiography than that predicted on ECG (odds ratio: 1.65 per 10 years (95% confidence interval (CI): 1.27-2.15), p = .0002, odds ratio: 1.17 per 10 mmHg (95% CI: 1.09-1.25), p < .0001, and odds ratio: 1.21 per 0.10 (95% CI: 1.02-1.42), p = .03). In addition, discrepancy was also seen in females and subjects receiving antihypertensive medication (odds ratio: 1.41 (95% CI: 1.04-1.89), p = .03 and odds ratio: 1.41 (95% CI: 1.06-1.87), p = .02), but FPG did not independently influence discrepancy between ECG and echocardiography.
Conclusion: Age, blood pressure, female sex, greater RWT and use of antihypertensive medication were associated with a greater risk of non-consistency between LVH determined by ECG and echocardiography.</description><identifier>ISSN: 0803-7051</identifier><identifier>EISSN: 1651-1999</identifier><identifier>DOI: 10.1080/08037051.2016.1235959</identifier><identifier>PMID: 27662908</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Aged ; Blood Glucose - metabolism ; Blood Pressure ; Cardiac and Cardiovascular Systems ; Clinical Medicine ; Discrepancy ; ECG ; Echocardiography ; Electrocardiography ; Female ; Humans ; Hypertrophy, Left Ventricular - blood ; Hypertrophy, Left Ventricular - diagnostic imaging ; Hypertrophy, Left Ventricular - physiopathology ; Kardiologi ; Klinisk medicin ; left ventricular hypertrophy ; left ventricular mass ; Male ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Middle Aged</subject><ispartof>Blood pressure, 2017-01, Vol.26 (1), p.54-63</ispartof><rights>2016 Scandinavian Foundation for Cardiovascular Research 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-9ac4aa0aa9353aca36d72a82048dac3d1054fbf85d1b4aa11c47666364cc7fee3</citedby><cites>FETCH-LOGICAL-c501t-9ac4aa0aa9353aca36d72a82048dac3d1054fbf85d1b4aa11c47666364cc7fee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27662908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/fc88e9b9-a029-44e9-9fe7-3bab61bd658f$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Petersen, Søren Sandager</creatorcontrib><creatorcontrib>Pedersen, Line Reinholdt</creatorcontrib><creatorcontrib>Pareek, Manan</creatorcontrib><creatorcontrib>Nielsen, Mette Lundgren</creatorcontrib><creatorcontrib>Diederichsen, Søren Zöga</creatorcontrib><creatorcontrib>Leósdóttir, Margrét</creatorcontrib><creatorcontrib>Nilsson, Peter M.</creatorcontrib><creatorcontrib>Diederichsen, Axel Cosmus Pyndt</creatorcontrib><creatorcontrib>Olsen, Michael Hecht</creatorcontrib><title>Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography</title><title>Blood pressure</title><addtitle>Blood Press</addtitle><description>Objective: To investigate the influence of cardiovascular risk factors, including fasting plasma glucose (FPG), on the association between electrocardiographic (ECG) and echocardiographic left ventricular hypertrophy (LVH) in an elderly population.
Methods: We tested cross-sectional associations between electrocardiographic and echocardiographic LVH, defining LVH according to the Sokolow-Lyon voltage combination, Cornell voltage-duration product, or left ventricular mass index (LVMI). Differences between standardized LVMI and Sokolow-Lyon voltage combination or Cornell voltage-duration product (absolute value/cut-off value for LVH) were used as outcome variables in order to identify explanatory variables associated with diagnostic discrepancies between ECG and echocardiography.
Results: Of the 1382 subjects included, 77% did not display any signs of LVH, 6% had LVH defined by ECG only, 13% had LVH defined by echocardiography only, and 5% had LVH on both ECG and echocardiography. Older subjects and those with higher blood pressure and RWT were more likely to have a relatively greater LVMI on echocardiography than that predicted on ECG (odds ratio: 1.65 per 10 years (95% confidence interval (CI): 1.27-2.15), p = .0002, odds ratio: 1.17 per 10 mmHg (95% CI: 1.09-1.25), p < .0001, and odds ratio: 1.21 per 0.10 (95% CI: 1.02-1.42), p = .03). In addition, discrepancy was also seen in females and subjects receiving antihypertensive medication (odds ratio: 1.41 (95% CI: 1.04-1.89), p = .03 and odds ratio: 1.41 (95% CI: 1.06-1.87), p = .02), but FPG did not independently influence discrepancy between ECG and echocardiography.
Conclusion: Age, blood pressure, female sex, greater RWT and use of antihypertensive medication were associated with a greater risk of non-consistency between LVH determined by ECG and echocardiography.</description><subject>Aged</subject><subject>Blood Glucose - metabolism</subject><subject>Blood Pressure</subject><subject>Cardiac and Cardiovascular Systems</subject><subject>Clinical Medicine</subject><subject>Discrepancy</subject><subject>ECG</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertrophy, Left Ventricular - blood</subject><subject>Hypertrophy, Left Ventricular - diagnostic imaging</subject><subject>Hypertrophy, Left Ventricular - physiopathology</subject><subject>Kardiologi</subject><subject>Klinisk medicin</subject><subject>left ventricular hypertrophy</subject><subject>left ventricular mass</subject><subject>Male</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><issn>0803-7051</issn><issn>1651-1999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9UsFu1DAQjRCILoVPAOXIJYsdx058A1UUKq3EBc7W2B7vpsrGwXZY5dZPx2G3lXrhMLI18-Y9zcwriveUbCnpyKccrCWcbmtCxZbWjEsuXxQbKjitqJTyZbFZMdUKuirexHhPCGWMkNfFVd0KUUvSbYqHWzDJh1hCjN70kNCWpz4dStvDfvQx9SZ_owk4wWiW0vlQDuhS-QfHFHozDxDKwzJhSMFPh6XUmE6IY4kDmpwyEGzv9wHWGoy2RHN4lnxbvHIwRHx3ea-LX7dff958r3Y_vt3dfNlVhhOaKgmmASAAknEGBpiwbQ1dTZrOgmGWEt447Tpuqc5ASk2TZxRMNMa0DpFdF3dnXuvhXk2hP0JYlIde_Uv4sFcQ8rQDKiqt5AaBZI1GEKFze6ZuuWAml5rMtTtzxRNOs37GNsxTDp1DRVTOdB1KLRWQWqqmQamkw1YxDVpQbQXvXKb7eKabgv89Y0zqmDeOwwAj-jkq2uWZu6ZtRYbyM9QEH2NA96RNiVp9oR59oVZfqIsvct-Hi8Ssj2ifuh6NkAGfz4B-zCc-wsmHwaoEy-CDC_n0fVTs_xp_Ab_Ny48</recordid><startdate>20170102</startdate><enddate>20170102</enddate><creator>Petersen, Søren Sandager</creator><creator>Pedersen, Line Reinholdt</creator><creator>Pareek, Manan</creator><creator>Nielsen, Mette Lundgren</creator><creator>Diederichsen, Søren Zöga</creator><creator>Leósdóttir, Margrét</creator><creator>Nilsson, Peter M.</creator><creator>Diederichsen, Axel Cosmus Pyndt</creator><creator>Olsen, Michael Hecht</creator><general>Taylor & Francis</general><general>Taylor & Francis Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope><scope>DOA</scope></search><sort><creationdate>20170102</creationdate><title>Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography</title><author>Petersen, Søren Sandager ; Pedersen, Line Reinholdt ; Pareek, Manan ; Nielsen, Mette Lundgren ; Diederichsen, Søren Zöga ; Leósdóttir, Margrét ; Nilsson, Peter M. ; Diederichsen, Axel Cosmus Pyndt ; Olsen, Michael Hecht</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-9ac4aa0aa9353aca36d72a82048dac3d1054fbf85d1b4aa11c47666364cc7fee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Blood Glucose - metabolism</topic><topic>Blood Pressure</topic><topic>Cardiac and Cardiovascular Systems</topic><topic>Clinical Medicine</topic><topic>Discrepancy</topic><topic>ECG</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertrophy, Left Ventricular - blood</topic><topic>Hypertrophy, Left Ventricular - diagnostic imaging</topic><topic>Hypertrophy, Left Ventricular - physiopathology</topic><topic>Kardiologi</topic><topic>Klinisk medicin</topic><topic>left ventricular hypertrophy</topic><topic>left ventricular mass</topic><topic>Male</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petersen, Søren Sandager</creatorcontrib><creatorcontrib>Pedersen, Line Reinholdt</creatorcontrib><creatorcontrib>Pareek, Manan</creatorcontrib><creatorcontrib>Nielsen, Mette Lundgren</creatorcontrib><creatorcontrib>Diederichsen, Søren Zöga</creatorcontrib><creatorcontrib>Leósdóttir, Margrét</creatorcontrib><creatorcontrib>Nilsson, Peter M.</creatorcontrib><creatorcontrib>Diederichsen, Axel Cosmus Pyndt</creatorcontrib><creatorcontrib>Olsen, Michael Hecht</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Blood pressure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petersen, Søren Sandager</au><au>Pedersen, Line Reinholdt</au><au>Pareek, Manan</au><au>Nielsen, Mette Lundgren</au><au>Diederichsen, Søren Zöga</au><au>Leósdóttir, Margrét</au><au>Nilsson, Peter M.</au><au>Diederichsen, Axel Cosmus Pyndt</au><au>Olsen, Michael Hecht</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography</atitle><jtitle>Blood pressure</jtitle><addtitle>Blood Press</addtitle><date>2017-01-02</date><risdate>2017</risdate><volume>26</volume><issue>1</issue><spage>54</spage><epage>63</epage><pages>54-63</pages><issn>0803-7051</issn><eissn>1651-1999</eissn><abstract>Objective: To investigate the influence of cardiovascular risk factors, including fasting plasma glucose (FPG), on the association between electrocardiographic (ECG) and echocardiographic left ventricular hypertrophy (LVH) in an elderly population.
Methods: We tested cross-sectional associations between electrocardiographic and echocardiographic LVH, defining LVH according to the Sokolow-Lyon voltage combination, Cornell voltage-duration product, or left ventricular mass index (LVMI). Differences between standardized LVMI and Sokolow-Lyon voltage combination or Cornell voltage-duration product (absolute value/cut-off value for LVH) were used as outcome variables in order to identify explanatory variables associated with diagnostic discrepancies between ECG and echocardiography.
Results: Of the 1382 subjects included, 77% did not display any signs of LVH, 6% had LVH defined by ECG only, 13% had LVH defined by echocardiography only, and 5% had LVH on both ECG and echocardiography. Older subjects and those with higher blood pressure and RWT were more likely to have a relatively greater LVMI on echocardiography than that predicted on ECG (odds ratio: 1.65 per 10 years (95% confidence interval (CI): 1.27-2.15), p = .0002, odds ratio: 1.17 per 10 mmHg (95% CI: 1.09-1.25), p < .0001, and odds ratio: 1.21 per 0.10 (95% CI: 1.02-1.42), p = .03). In addition, discrepancy was also seen in females and subjects receiving antihypertensive medication (odds ratio: 1.41 (95% CI: 1.04-1.89), p = .03 and odds ratio: 1.41 (95% CI: 1.06-1.87), p = .02), but FPG did not independently influence discrepancy between ECG and echocardiography.
Conclusion: Age, blood pressure, female sex, greater RWT and use of antihypertensive medication were associated with a greater risk of non-consistency between LVH determined by ECG and echocardiography.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>27662908</pmid><doi>10.1080/08037051.2016.1235959</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0803-7051 |
| ispartof | Blood pressure, 2017-01, Vol.26 (1), p.54-63 |
| issn | 0803-7051 1651-1999 |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_08037051_2016_1235959 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Aged Blood Glucose - metabolism Blood Pressure Cardiac and Cardiovascular Systems Clinical Medicine Discrepancy ECG Echocardiography Electrocardiography Female Humans Hypertrophy, Left Ventricular - blood Hypertrophy, Left Ventricular - diagnostic imaging Hypertrophy, Left Ventricular - physiopathology Kardiologi Klinisk medicin left ventricular hypertrophy left ventricular mass Male Medical and Health Sciences Medicin och hälsovetenskap Middle Aged |
| title | Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A00%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20diagnostic%20discrepancy%20for%20left%20ventricular%20hypertrophy%20between%20electrocardiography%20and%20echocardiography&rft.jtitle=Blood%20pressure&rft.au=Petersen,%20S%C3%B8ren%20Sandager&rft.date=2017-01-02&rft.volume=26&rft.issue=1&rft.spage=54&rft.epage=63&rft.pages=54-63&rft.issn=0803-7051&rft.eissn=1651-1999&rft_id=info:doi/10.1080/08037051.2016.1235959&rft_dat=%3Cproquest_cross%3E1835384776%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835384776&rft_id=info:pmid/27662908&rft_doaj_id=oai_doaj_org_article_19d95cea06d74606bee3bf87563c9d94&rfr_iscdi=true |